intervention formula 2

OTHER2 trials

Sponsors

HiPP GmbH & Co. Vertrieb KG

Conditions

Disturbance of GrowthInfantile Colic

Unknown Phase

Low-protein Infant Formula With Partial or Extensive Proteinhydrolysate 4 Year Follow-up

CompletedNCT01143233

HiPP GmbH & Co. Vertrieb KGDisturbance of Growth

Start: 2010-04-30End: 2017-08-31Updated: 2017-11-30

Evaluation of Safety and Efficacy of New Infant Formula in Infantile Colic

TerminatedNCT01721850

HiPP GmbH & Co. Vertrieb KGInfantile Colic

Start: 2011-12-31End: 2019-04-30Updated: 2022-01-20

Related Papers

Hydrolyzed Formula With Reduced Protein Content Supports Adequate Growth

Journal of Pediatric Gastroenterology and Nutrition2017-12-0517 citations